Ünal, Türkan
Kuran, Alican
Gulsen, Ibrahim Tevfik
Kızılay, Fatma Nur
Gulsen, Emine
Özüdoğru, Semanur
Gördeli, Kadir
Celik, Ozer
Uğurlu, Mehmet
Bayrakdar, İbrahim Şevki
Orhan, Kaan
Article History
Received: 26 June 2025
Accepted: 3 October 2025
First Online: 23 December 2025
Declarations
:
: Written informed consent was obtained from all participants (or their legal guardians) for the use and publication of their radiological images and anonymized data. The study was approved by the Non-Interventional Clinical Research Ethics Committee of Eskisehir Osmangazi University (Approval No: 04.10.2022/22).
: Not applicable.
: Ibrahim Sevki Bayrakdar reports a relationship with CranioCatch that includes: board membership and equity or stocks. Dr. Ibrahim Sevki Bayrakdar is the Co-founder and CEO of CranioCatch, a company specializing in the development of advanced artificial intelligence solutions for use in dentistry and related fields. In his role, he oversees company operations, strategic planning, and product development. Given his professional role and business interests in CranioCatch, there may be a potential conflict of interest regarding the content of this article. While every effort has been made to ensure an objective and balanced perspective, readers are advised to consider this potential influence. Dr. Bayrakdar remains committed to ethical conduct, transparency, and integrity in all academic and professional activities. As other authors, we do not have any conflict of interest to disclose. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.